Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 13, Issue 4 pp 6041—6054
Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis
Figure 8. CERS6-AS1 knockdown impairs the tumor growth of PDAC cells in vivo. (A) Tumor growth was monitored by measuring tumor volumes in 6-day intervals. (B) Representative images of tumor xenografts obtained from the sh-CERS6-AS1 and sh-NC groups. (C) The tumor xenografts removed from mice at 30 days after the injection of SW1990 cells stably overexpressing sh-CERS6-AS1 or sh-NC. The weights of xenografts were detected. (D) The level of CERS6-AS1 in xenografts was evaluated by RT-qPCR. (E) miR-15a-5p expression in the xenografts was determined by RT-qPCR. (F) Western blotting was used to measure FGFR1 protein expression in xenografts. **P < 0.01.